PPT-DNA vaccination against drug resistance in chronic viral infections, example of HIV-1

Isaguliants Maria Department of Microbiology Tumor and Cell Biology Karolinska Institutet Stockholm Sweden A Kirhenstein Institute of Microbiology and Virology Riga Stradins University Riga Latvia. Despite this signi64257cant progress the number of children becoming newly infected with HIV remains unacceptably high About 240 000 210 000280 000 children became infected with HIV in 2013 The risk of a mother living with HIV passing the virus to h brPage 1br New HIV Infections Estimates of New HIV Infections in the United States for the MostA57375ected Subpopulations 2010 0 2000 4000 6000 8000 10000 12000 Blacks African Americ KarlineSoetaert3example(image3D)example(contour3D)example(colkey)example(jet.col)example(perspbox)example(mesh)example(trans3D)example(plot.plist)example(ImageOcean)example(Oxsat)2.Functionsimage2Dand HIV. & . AIDS. . Hepatitis. Herpes Virus. Influenza. . Chapter 36. 1. Demographics. World-wide in 2006: 65 Million people living with HIV/AIDS. U.S.: . 1.1. Million cases to date:. 40,000 new cases each year. Meeting. . HIV/Viral Hepatitis: . Improving Diagnosis, Antiviral Therapy and . Access. Sunday, 17 July 2016. Durban, South Africa. . Council of State and Territorial Epidemiologists Annual Conference. June 4, 2012. Omaha, Nebraska. Tom Jaenicke, MPH, MBA, MES. Washington State Department of Health. Tom.Jaenicke@doh.wa.gov. Outline for today. Camille Angle, Meagan Bardan, Hanna Schimjawicz and Sean Tabarah. PHM142 Fall . 2018. Instructor: . Ms. Maya Latif. Coordinator: Dr. J. Henderson. HIV Attachment and Penetration. Wilen, C. B., Tilton, J. C., & Doms, R. W. D. (2012). HIV: Cell binding and entry. . Virus (HIV) . Infection. Zoya. . Minasyan. RN-MSN-. Edu. Significance of Problem. Globally. 33 million living with HIV. 2.7 million new infections each year. 2 million HIV-related deaths each year. Ireen Kiwelu. Kilimanjaro International PhD symposium. KCMC, Nov 28, 2013. Supervisors. Prof. . Max . Essex. 1. Dr. . Vladmir. . Novitsky. 1. Prof. . Saidi. . Kapiga. . 2. . Dr. Rachel Manongi. Claude MUVUNYI M.D., Ph.D.. Viral diseases. The relative susceptibility of a person and the severity of the disease depend on factors such as: . the . nature of exposure; . the . immune status, . age. HIV1 and slower to progress to AIDS.. Most cases are due to type1.. Modes of transmission. 1-sexual.. 2- perinatal.. 3-parenteral(occupational and intravenous drug injection).. 4- blood transfusion.. Presented by Idaho Advisory Council on HIV and AIDS,. Bebe Thompson, Co-Chair. 1. Idaho Advisory Council on HIV and AIDS. Community based group that advises the state . Planning, development and review of HIV care, prevention and viral hepatitis state program plans (continuum of care). IDOXURIDINE trifloride. GANCICLOVIR . . . 1. DIDANOSINE (DDI). Nomenclature:. 9-(5-. (. hydroxy methyl)tetrahydrofuran-2-yl. )-3H-purin-6(9H)-one. Didanosine . is a . purine 2',3'-dideoxyribonucleoside that is inosine in which the hydroxy groups at both the 2' and the 3' positions on the sugar moiety have been replaced by hydrogen. exanthem. . د. محمد يوسف حسن. Mumpus. virus( paramyxoviruses ).. parotid glands.. It is endemic worldwide and peaks at . 5–9 . yrs. . of age.. . Vaccination. has reduced childhood .